Natixis Has $65.35 Million Stake in Intuitive Surgical, Inc. $ISRG

Natixis raised its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 30.7% during the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 120,254 shares of the medical equipment provider’s stock after buying an additional 28,274 shares during the quarter. Natixis’ holdings in Intuitive Surgical were worth $65,347,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Aaron Wealth Advisors LLC increased its stake in shares of Intuitive Surgical by 0.8% in the second quarter. Aaron Wealth Advisors LLC now owns 2,528 shares of the medical equipment provider’s stock worth $1,374,000 after acquiring an additional 19 shares during the last quarter. Evergreen Capital Management LLC increased its position in Intuitive Surgical by 0.5% in the 1st quarter. Evergreen Capital Management LLC now owns 4,288 shares of the medical equipment provider’s stock worth $2,124,000 after purchasing an additional 20 shares during the last quarter. Rise Advisors LLC raised its stake in shares of Intuitive Surgical by 5.6% during the 1st quarter. Rise Advisors LLC now owns 378 shares of the medical equipment provider’s stock worth $187,000 after purchasing an additional 20 shares in the last quarter. Pinnacle Bancorp Inc. raised its stake in shares of Intuitive Surgical by 4.1% during the 2nd quarter. Pinnacle Bancorp Inc. now owns 532 shares of the medical equipment provider’s stock worth $289,000 after purchasing an additional 21 shares in the last quarter. Finally, City Holding Co. lifted its holdings in shares of Intuitive Surgical by 16.1% during the 2nd quarter. City Holding Co. now owns 159 shares of the medical equipment provider’s stock valued at $86,000 after buying an additional 22 shares during the last quarter. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Wall Street Analysts Forecast Growth

Several analysts have commented on the stock. Deutsche Bank Aktiengesellschaft reissued a “sell” rating on shares of Intuitive Surgical in a research report on Friday, August 22nd. Jefferies Financial Group increased their target price on shares of Intuitive Surgical from $550.00 to $560.00 and gave the stock a “hold” rating in a research report on Wednesday, October 22nd. Daiwa Capital Markets boosted their price target on Intuitive Surgical from $510.00 to $550.00 and gave the stock an “outperform” rating in a research report on Friday, October 24th. The Goldman Sachs Group upped their price target on Intuitive Surgical from $567.00 to $621.00 and gave the stock a “buy” rating in a research note on Wednesday, October 22nd. Finally, Wall Street Zen cut Intuitive Surgical from a “buy” rating to a “hold” rating in a research report on Saturday. Two investment analysts have rated the stock with a Strong Buy rating, seventeen have issued a Buy rating, seven have issued a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, Intuitive Surgical presently has a consensus rating of “Moderate Buy” and a consensus price target of $607.17.

Insider Transactions at Intuitive Surgical

In other news, CEO David J. Rosa sold 24,500 shares of Intuitive Surgical stock in a transaction on Friday, October 24th. The stock was sold at an average price of $547.55, for a total value of $13,414,975.00. Following the completion of the sale, the chief executive officer directly owned 234,256 shares of the company’s stock, valued at approximately $128,266,872.80. This trade represents a 9.47% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, EVP Henry L. Charlton sold 13,731 shares of the firm’s stock in a transaction dated Wednesday, November 12th. The shares were sold at an average price of $580.00, for a total value of $7,963,980.00. Following the completion of the transaction, the executive vice president owned 3,056 shares in the company, valued at approximately $1,772,480. This represents a 81.80% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last three months, insiders sold 108,939 shares of company stock worth $60,757,995. Corporate insiders own 0.70% of the company’s stock.

Intuitive Surgical Stock Up 1.2%

Shares of Intuitive Surgical stock opened at $575.34 on Monday. The stock has a market capitalization of $206.25 billion, a P/E ratio of 76.10, a price-to-earnings-growth ratio of 5.29 and a beta of 1.68. The company has a 50-day simple moving average of $518.60 and a 200 day simple moving average of $505.04. Intuitive Surgical, Inc. has a 12-month low of $425.00 and a 12-month high of $616.00.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings data on Tuesday, October 21st. The medical equipment provider reported $2.40 EPS for the quarter, topping analysts’ consensus estimates of $1.99 by $0.41. Intuitive Surgical had a net margin of 28.58% and a return on equity of 15.08%. The firm had revenue of $2.51 billion for the quarter, compared to analyst estimates of $2.41 billion. During the same quarter in the prior year, the firm earned $1.84 EPS. The company’s revenue was up 22.9% on a year-over-year basis. On average, equities analysts anticipate that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.